Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life.

Hurst JR, Skolnik N, Hansen GJ, Anzueto A, Donaldson GC, Dransfield MT, Varghese P.

Eur J Intern Med. 2020 Jan 16. pii: S0953-6205(19)30443-1. doi: 10.1016/j.ejim.2019.12.014. [Epub ahead of print] Review.

2.

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.

Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine Iii R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB; NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).

Int J Chron Obstruct Pulmon Dis. 2019 Dec 20;14:2927-2938. doi: 10.2147/COPD.S220164. eCollection 2019.

3.

End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.

Iyer AS, Goodrich CA, Dransfield MT, Alam SS, Brown CJ, Landefeld CS, Bakitas MA, Brown JR.

Am J Med. 2019 Dec 26. pii: S0002-9343(19)31105-2. doi: 10.1016/j.amjmed.2019.11.024. [Epub ahead of print]

PMID:
31883772
4.

Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPD.

Sharifov OF, Denney TS Jr, Wells JM, Payne GA, Gulati S, Gupta H, Dransfield MT, Lloyd SG.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 2;14:2753-2757. doi: 10.2147/COPD.S220868. eCollection 2019. No abstract available.

5.

Clinical Development and Research Applications of the COPD Assessment Test (CAT).

Müllerová H, Dransfield MT, Thomashow B, Jones PW, Rennard S, Karlsson N, Fageras M, Metzdorf N, Petruzzelli S, Rommes J, Sciurba FC, Tabberer M, Merrill D, Tal-Singer R; COPD Biomarker Qualification Consortium and the CAT Governance Board.

Am J Respir Crit Care Med. 2019 Dec 9. doi: 10.1164/rccm.201907-1369PP. [Epub ahead of print]

PMID:
31815521
6.

Exacerbations of chronic obstructive pulmonary disease: time to rename.

Bafadhel M, Criner G, Dransfield MT, Janssens W, McDonald VM, Vogelmeier CF, Russell RE, Collis P.

Lancet Respir Med. 2019 Nov 27. pii: S2213-2600(19)30414-X. doi: 10.1016/S2213-2600(19)30414-X. [Epub ahead of print] No abstract available.

PMID:
31786125
7.

Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene.

LaFon DC, Bhatt SP, Labaki WW, Rahaghi FN, Moll M, Bowler RP, Regan EA, Make BJ, Crapo JD, San Jose Estepar R, Diaz AA, Silverman EK, Han MK, Hobbs B, Cho MH, Washko GR, Dransfield MT, Wells JM; COPDGene Investigators.

Eur Respir J. 2019 Nov 26. pii: 1901812. doi: 10.1183/13993003.01812-2019. [Epub ahead of print] No abstract available.

PMID:
31772001
8.

Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.

Parekh TM, Bhatia S, Cherrington A, Kim YI, Lambert A, Iyer A, Regan EA, DeMeo DL, Han M, Dransfield MT.

Respir Med. 2019 Nov 15;161:105820. doi: 10.1016/j.rmed.2019.105820. [Epub ahead of print]

PMID:
31759270
9.

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS.

Wells JM, Xing D, Viera L, Burkes RM, Wu Y, Bhatt SP, Dransfield MT, Couper DJ, O'Neal W, Hoffman EA, Gaggar A, Barjaktarevic I, Curtis JL, Labaki WW, Han MLK, Freeman CM, Putcha N, Schlange T, Blalock JE; SPIROMICS Investigators,.

Respir Res. 2019 Nov 12;20(1):254. doi: 10.1186/s12931-019-1230-8.

10.

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Lowe KE, Regan EA, Anzueto A, Austin E, Austin JHM, Beaty TH, Benos PV, Benway CJ, Bhatt SP, Bleecker ER, Bodduluri S, Bon J, Boriek AM, Boueiz AR, Bowler RP, Budoff M, Casaburi R, Castaldi PJ, Charbonnier JP, Cho MH, Comellas A, Conrad D, Costa Davis C, Criner GJ, Curran-Everett D, Curtis JL, DeMeo DL, Diaz AA, Dransfield MT, Dy JG, Fawzy A, Fleming M, Flenaugh EL, Foreman MG, Fortis S, Gebrekristos H, Grant S, Grenier PA, Gu T, Gupta A, Han MK, Hanania NA, Hansel NN, Hayden LP, Hersh CP, Hobbs BD, Hoffman EA, Hogg JC, Hokanson JE, Hoth KF, Hsiao A, Humphries S, Jacobs K, Jacobson FL, Kazerooni EA, Kim V, Kim WJ, Kinney GL, Koegler H, Lutz SM, Lynch DA, MacIntye NR Jr, Make BJ, Marchetti N, Martinez FJ, Maselli DJ, Mathews AM, McCormack MC, McDonald MN, McEvoy CE, Moll M, Molye SS, Murray S, Nath H, Newell JD Jr, Occhipinti M, Paoletti M, Parekh T, Pistolesi M, Pratte KA, Putcha N, Ragland M, Reinhardt JM, Rennard SI, Rosiello RA, Ross JC, Rossiter HB, Ruczinski I, San Jose Estepar R, Sciurba FC, Sieren JC, Singh H, Soler X, Steiner RM, Strand MJ, Stringer WW, Tal-Singer R, Thomashow B, Vegas Sánchez-Ferrero G, Walsh JW, Wan ES, Washko GR, Michael Wells J, Wendt CH, Westney G, Wilson A, Wise RA, Yen A, Young K, Yun J, Silverman EK, Crapo JD.

Chronic Obstr Pulm Dis. 2019 Nov;6(5):384-399. doi: 10.15326/jcopdf.6.5.2019.0149.

11.

A Qualitative Study of Pulmonary and Palliative Care Clinician Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease.

Iyer AS, Dionne-Odom JN, Khateeb DM, O'Hare L, Tucker RO, Brown CJ, Dransfield MT, Bakitas MA.

J Palliat Med. 2019 Oct 29. doi: 10.1089/jpm.2019.0355. [Epub ahead of print]

PMID:
31657654
12.

Metoprolol for the Prevention of Acute Exacerbations of COPD.

Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoğlu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE; BLOCK COPD Trial Group.

N Engl J Med. 2019 Dec 12;381(24):2304-2314. doi: 10.1056/NEJMoa1908142. Epub 2019 Oct 20.

PMID:
31633896
13.

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease.

Mkorombindo T, Dransfield MT.

Int J Chron Obstruct Pulmon Dis. 2019 Aug 7;14:1779-1787. doi: 10.2147/COPD.S162781. eCollection 2019.

14.

Misinterpretation of time-to-first event curves can lead to inappropriate treatment.

Hartley B, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lipson DA, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Lettis S.

Eur Respir J. 2019 Sep 5;54(3). pii: 1900634. doi: 10.1183/13993003.00634-2019. Print 2019 Sep. No abstract available.

PMID:
31488584
15.

Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.

Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Paine R 3rd, Peters SP, Rennard SI, Woodruff PG; SPIROMICS Investigators.

Eur Respir J. 2019 Oct 31;54(4). pii: 1802214. doi: 10.1183/13993003.02214-2018. Print 2019 Oct.

PMID:
31439683
16.

COPD exacerbations and MACE: More than a chance encounter?

Mkorombindo T, Dransfield MT.

Respirology. 2019 Dec;24(12):1129-1130. doi: 10.1111/resp.13683. Epub 2019 Aug 21. No abstract available.

17.

Reply to Gagnon et al.: Video Teleheath and Pulmonary Rehabilitation: Need for a Better Understanding.

Bhatt SP, Dransfield MT.

Am J Respir Crit Care Med. 2020 Jan 1;201(1):120. doi: 10.1164/rccm.201907-1486LE. No abstract available.

18.

Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study.

Washko GR, Colangelo LA, Estépar RSJ, Ash SY, Bhatt SP, Okajima Y, Liu K, Jacobs DR Jr, Iribarren C, Thyagarajan B, Lewis CE, Kumar R, Han MK, Dransfield MT, Carnethon MR, Kalhan R.

Am J Med. 2020 Feb;133(2):222-230.e11. doi: 10.1016/j.amjmed.2019.06.049. Epub 2019 Jul 29.

PMID:
31369720
19.

Adherence to Pulmonary Rehabilitation in COPD: A QUALITATIVE EXPLORATION OF PATIENT PERSPECTIVES ON BARRIERS AND FACILITATORS.

Oates GR, Niranjan SJ, Ott C, Scarinci IC, Schumann C, Parekh T, Dransfield MT.

J Cardiopulm Rehabil Prev. 2019 Sep;39(5):344-349. doi: 10.1097/HCR.0000000000000436.

PMID:
31348127
20.

Reply to Moy: Not All Home-based Exercise Programs Are Home-based Pulmonary Rehabilitation Programs.

Bhatt SP, Dransfield MT.

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1443-1444. doi: 10.1164/rccm.201907-1287LE. No abstract available.

21.

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Pascoe S, Barnes N, Brusselle G, Compton C, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Hartley B, Lange P, Lettis S, Lipson DA, Lomas DA, Martinez FJ, Papi A, Roche N, van der Valk RJP, Wise R, Singh D.

Lancet Respir Med. 2019 Sep;7(9):745-756. doi: 10.1016/S2213-2600(19)30190-0. Epub 2019 Jul 4.

PMID:
31281061
22.

Application of the community health worker model in adult asthma and COPD in the U.S.: a systematic review.

Parekh TM, Copeland CR, Dransfield MT, Cherrington A.

BMC Pulm Med. 2019 Jun 26;19(1):116. doi: 10.1186/s12890-019-0878-7.

23.

Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.

Bhatt SP, Balte PP, Schwartz JE, Cassano PA, Couper D, Jacobs DR Jr, Kalhan R, O'Connor GT, Yende S, Sanders JL, Umans JG, Dransfield MT, Chaves PH, White WB, Oelsner EC.

JAMA. 2019 Jun 25;321(24):2438-2447. doi: 10.1001/jama.2019.7233.

24.

Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ.

Chest. 2019 Aug;156(2):228-238. doi: 10.1016/j.chest.2019.04.135. Epub 2019 May 30. Review.

PMID:
31154041
25.

Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: a cross-sectional analysis of the REGARDS study.

Parekh TM, Wu C, McClure LA, Howard VJ, Cushman M, Malek AM, Harrington KF, Cherrington AL, Dransfield MT, Bhatia S.

BMJ Open. 2019 May 10;9(5):e027175. doi: 10.1136/bmjopen-2018-027175.

26.

A Formative Evaluation of Patient and Family Caregiver Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease across Disease Severity.

Iyer AS, Dionne-Odom JN, Ford SM, Crump Tims SL, Sockwell ED, Ivankova NV, Brown CJ, Tucker RO, Dransfield MT, Bakitas MA.

Ann Am Thorac Soc. 2019 Aug;16(8):1024-1033. doi: 10.1513/AnnalsATS.201902-112OC.

PMID:
31039003
27.

Video Telehealth Pulmonary Rehabilitation Intervention in Chronic Obstructive Pulmonary Disease Reduces 30-Day Readmissions.

Bhatt SP, Patel SB, Anderson EM, Baugh D, Givens T, Schumann C, Sanders JG, Windham ST, Cutter GR, Dransfield MT.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):511-513. doi: 10.1164/rccm.201902-0314LE. No abstract available.

PMID:
30978302
28.

A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.

Oelsner EC, Ortega VE, Smith BM, Nguyen JN, Manichaikul AW, Hoffman EA, Guo X, Taylor KD, Woodruff PG, Couper DJ, Hansel NN, Martinez FJ, Paine R 3rd, Han MK, Cooper C, Dransfield MT, Criner G, Krishnan JA, Bowler R, Bleecker ER, Peters S, Rich SS, Meyers DA, Rotter JI, Barr RG.

Am J Respir Crit Care Med. 2019 Sep 15;200(6):721-731. doi: 10.1164/rccm.201812-2355OC.

PMID:
30925230
29.

Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Fortis S, Comellas A, Make BJ, Hersh CP, Bodduluri S, Georgopoulos D, Kim V, Criner GJ, Dransfield MT, Bhatt SP; COPDGene Investigators–Core Units: <italic>Administrative Center</italic>, COPDGene Investigators–Clinical Centers: <italic>Ann Arbor VA</italic>.

Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.

PMID:
30908927
30.

The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.

Bhatt SP, Bodduluri S, Raghav V, Bhakta NR, Wilson CG, Kim YI, Eberlein M, Sciurba FC, Han MK, Dransfield MT, Nakhmani A.

Ann Am Thorac Soc. 2019 Aug;16(8):982-989. doi: 10.1513/AnnalsATS.201811-812OC.

PMID:
30865842
31.

Effect of daily azithromycin therapy and adherence on readmission risk in COPD.

Krishnan JK, Voelker H, Connett JE, Niewoehner DE, Albert RK, Scanlon PD, Criner GJ, Dransfield MT, Han MK, Martinez FJ; COPD Clinical Research Network Investigators.

Eur Respir J. 2019 Mar 18;53(3). pii: 1801377. doi: 10.1183/13993003.01377-2018. Print 2019 Mar. No abstract available.

PMID:
30819817
32.

Chronic Obstructive Pulmonary Disease in America's Black Population.

Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH, Han MK.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):423-430. doi: 10.1164/rccm.201810-1909PP. No abstract available.

PMID:
30789750
33.

Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.

Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF; COPDGene Investigators.

J Psychosom Res. 2019 Mar;118:18-26. doi: 10.1016/j.jpsychores.2019.01.002. Epub 2019 Jan 7.

PMID:
30782350
34.

Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Washko GR, Nardelli P, Ash SY, Vegas Sanchez-Ferrero G, Rahaghi FN, Come CE, Dransfield MT, Kalhan R, Han MK, Bhatt SP, Wells JM, Aaron CP, Diaz AA, Ross JC, Cuttica MJ, Labaki WW, Querejeta Roca G, Shah AM, Young K, Kinney GL, Hokanson JE, Agustí A, San José Estépar R.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461. doi: 10.1164/rccm.201811-2063OC.

PMID:
30758975
35.

Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.

Press VG, Au DH, Bourbeau J, Dransfield MT, Gershon AS, Krishnan JA, Mularski RA, Sciurba FC, Sullivan J, Feemster LC.

Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.

PMID:
30707066
36.

Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.

Garudadri S, Woodruff PG, Han MK, Curtis JL, Barr RG, Bleecker ER, Bowler RP, Comellas A, Cooper CB, Criner G, Dransfield MT, Hansel NN, Paine R 3rd, Krishnan JA, Peters SP, Hastie AT, Martinez FJ, O'Neal WK, Couper DJ, Alexis NE, Christenson SA.

Chest. 2019 May;155(5):908-917. doi: 10.1016/j.chest.2018.12.022. Epub 2019 Jan 23.

PMID:
30684474
37.

Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy.

Wells JM, Arenberg DA, Barjaktarevic I, Bhatt SP, Bowler RP, Christenson SA, Couper DJ, Dransfield MT, Han MK, Hoffman EA, Kaner RJ, Kim V, Kleerup E, Martinez FJ, Moore WC, O'Beirne SL, Paine R 3rd, Putcha N, Raman SM, Barr RG, Rennard SI, Woodruff PG, Curtis JL.

Ann Am Thorac Soc. 2019 Apr;16(4):439-446. doi: 10.1513/AnnalsATS.201807-441OC.

PMID:
30653926
38.

Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.

Genschmer KR, Russell DW, Lal C, Szul T, Bratcher PE, Noerager BD, Abdul Roda M, Xu X, Rezonzew G, Viera L, Dobosh BS, Margaroli C, Abdalla TH, King RW, McNicholas CM, Wells JM, Dransfield MT, Tirouvanziam R, Gaggar A, Blalock JE.

Cell. 2019 Jan 10;176(1-2):113-126.e15. doi: 10.1016/j.cell.2018.12.002.

39.

Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.

Fawzy A, Putcha N, Aaron CP, Bowler RP, Comellas AP, Cooper CB, Dransfield MT, Han MK, Hoffman EA, Kanner RE, Krishnan JA, Labaki WW, Paine R 3rd, Paulin LM, Peters SP, Wise R, Barr RG, Hansel NN; SPIROMICS Investigators.

Chest. 2019 Mar;155(3):519-527. doi: 10.1016/j.chest.2018.11.028. Epub 2018 Dec 26.

PMID:
30593776
40.

Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction.

Mamary AJ, Stewart JI, Kinney GL, Hokanson JE, Shenoy K, Dransfield MT, Foreman MG, Vance GB, Criner GJ; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2018 Jul 2;5(3):177-184. doi: 10.15326/jcopdf.5.3.2017.0145.

41.

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.

Bhatt SP, Nath HP, Kim YI, Ramachandran R, Watts JR, Terry NLJ, Sonavane S, Deshmane SP, Woodruff PG, Oelsner EC, Bodduluri S, Han MK, Labaki WW, Michael Wells J, Martinez FJ, Barr RG, Dransfield MT; SPIROMICS investigators.

Respir Res. 2018 Dec 18;19(1):257. doi: 10.1186/s12931-018-0946-1.

42.

Lung Function in Young Adults and Risk of Cardiovascular Events Over 29 Years: The CARDIA Study.

Cuttica MJ, Colangelo LA, Dransfield MT, Bhatt SP, Rana JS, Jacobs DR Jr, Thyagarajan B, Sidney S, Lewis CE, Liu K, Lloyd-Jones D, Washko G, Kalhan R.

J Am Heart Assoc. 2018 Dec 18;7(24):e010672. doi: 10.1161/JAHA.118.010672.

43.

Airway fractal dimension predicts respiratory morbidity and mortality in COPD.

Bodduluri S, Puliyakote ASK, Gerard SE, Reinhardt JM, Hoffman EA, Newell JD Jr, Nath HP, Han MK, Washko GR, San José Estépar R, Dransfield MT, Bhatt SP; COPDGene Investigators.

J Clin Invest. 2018 Dec 3;128(12):5676. doi: 10.1172/JCI125987. Epub 2018 Dec 3. No abstract available.

44.

New Spirometry Indices for Detecting Mild Airflow Obstruction.

Bhatt SP, Bhakta NR, Wilson CG, Cooper CB, Barjaktarevic I, Bodduluri S, Kim YI, Eberlein M, Woodruff PG, Sciurba FC, Castaldi PJ, Han MK, Dransfield MT, Nakhmani A.

Sci Rep. 2018 Nov 30;8(1):17484. doi: 10.1038/s41598-018-35930-2.

45.

Inflammation and endothelial activation in early adulthood are associated with future emphysema: the CARDIA Lung Study.

Wells JM, Colangelo LA, Sivarajan L, Thyagarajan B, Dransfield MT, Iribarren C, Reyfman PA, Jacobs DR, Washko GR, Kalhan R.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801532. doi: 10.1183/13993003.01532-2018. Print 2019 Jan. No abstract available.

PMID:
30464011
46.

Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.

Wells JM, Parker MM, Oster RA, Bowler RP, Dransfield MT, Bhatt SP, Cho MH, Kim V, Curtis JL, Martinez FJ, Paine R 3rd, O'Neal W, Labaki WW, Kaner RJ, Barjaktarevic I, Han MK, Silverman EK, Crapo JD, Barr RG, Woodruff P, Castaldi PJ, Gaggar A; SPIROMICS and COPDGene Investigators.

JCI Insight. 2018 Nov 15;3(22). pii: 123614. doi: 10.1172/jci.insight.123614.

47.

Interpreting Recent Developments in COPD Treatments.

Sethi S, Dransfield MT.

J Fam Pract. 2018 Oct;67(10 Suppl):S33-S39. No abstract available.

PMID:
30423009
48.

Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema.

Aggarwal S, Ahmad I, Lam A, Carlisle MA, Li C, Wells JM, Raju SV, Athar M, Rowe SM, Dransfield MT, Matalon S.

JCI Insight. 2018 Nov 2;3(21). pii: 120694. doi: 10.1172/jci.insight.120694.

49.

Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.

Seo M, Qiu W, Bailey W, Criner GJ, Dransfield MT, Fuhlbrigge AL, Reilly JJ, Scholand MB, Castaldi P, Chase R, Parker M, Saferali A, Yun JH, Crapo JD, Cho MH, Beaty TH, Silverman EK, Hersh CP.

J Mol Med (Berl). 2018 Dec;96(12):1375-1385. doi: 10.1007/s00109-018-1708-8. Epub 2018 Oct 23.

50.

Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort.

Paulin LM, Smith BM, Koch A, Han M, Hoffman EA, Martinez C, Ejike C, Blanc PD, Rous J, Barr RG, Peters SP, Paine R 3rd, Pirozzi C, Cooper CB, Dransfield MT, Comellas AP, Kanner RE, Drummond MB, Putcha N, Hansel NN.

Ann Am Thorac Soc. 2018 Dec;15(12):1411-1419. doi: 10.1513/AnnalsATS.201802-150OC.

Supplemental Content

Loading ...
Support Center